Dihydrocaffeic acid derivatives, use thereof for medical treatments and pharmaceutical preparations containing same
申请人:MITSUI TOATSU CHEMICALS, Inc.
公开号:EP0418065A2
公开(公告)日:1991-03-20
Dihydrocaffeic acid derivatives are disclosed which are applicable as medicines having excellent absorbency in the case of oral administration and good concentration retention in blood.
The disclosed compounds have the function to induce the production and secretion of a nerve growth factor (NGF) in the brain tissue, and accordingly are effective as medicines for inhibiting the progression of regressive disorders of the central nervous system and for the therapeutic treatment of such disorders.
本发明公开了二氢咖啡酸衍生物,这些衍生物可作为药物使用,在口服情况下具有极佳的吸收性和良好的血液浓度保持性。
所公开的化合物具有诱导脑组织产生和分泌神经生长因子(NGF)的功能,因此可有效抑制中枢神经系统退行性疾病的发展,并对此类疾病进行治疗。